, Volume 154, Issue 5, pp 594-596
Date: 17 Mar 2013

Analysis of the Application of MMP-9 Inhibitor in Skin Melanoma: Experimental Study

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Experiment on C57Bl/6 mice with modeled skin melanoma showed that selective inhibition of matrix metalloproteinase-9 increased lifetime and reduced the number of PCNA+ tumor cells and intensity of neoangiogenesis. Inhibition of matrix metalloproteinase-9 prevented tumor necrosis. The results suggest that matrix metalloproteinase-9 is involved not only in the regulation of extracellular matrix degradation, but also in the processes of cell proliferation and neoangiogenesis in skin melanoma. Therefore, this enzyme can be considered as a potential therapeutic target.